267 related articles for article (PubMed ID: 21628855)
81. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
82. Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5' region of BCL2 in B-cell tumors.
Yonetani N; Ueda C; Akasaka T; Nishikori M; Uchiyama T; Ohno H
Jpn J Cancer Res; 2001 Sep; 92(9):933-40. PubMed ID: 11572760
[TBL] [Abstract][Full Text] [Related]
83. Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy.
Zhang J; Shi Y; Zhao M; Hu H; Huang H
Sci Rep; 2020 Aug; 10(1):14164. PubMed ID: 32843697
[TBL] [Abstract][Full Text] [Related]
84. Molecular analysis of the t(2;8)/MYC-IGK translocation in high-grade lymphoma/leukemia by long-distance inverse PCR.
Kroenlein H; Schwartz S; Reinhardt R; Rieder H; Molkentin M; Gökbuget N; Hoelzer D; Thiel E; Burmeister T
Genes Chromosomes Cancer; 2012 Mar; 51(3):290-9. PubMed ID: 22120970
[TBL] [Abstract][Full Text] [Related]
85. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
[TBL] [Abstract][Full Text] [Related]
86. Novel three-break rearrangement and cryptic translocations leading to colocalization of MYC and IGH signals in B-cell acute lymphoblastic leukemia.
Tchinda J; Volpert S; Berdel WE; Büchner T; Horst J
Cancer Genet Cytogenet; 2006 Mar; 165(2):180-4. PubMed ID: 16527615
[TBL] [Abstract][Full Text] [Related]
87. A clinician's guide to double hit lymphomas.
Cheah CY; Oki Y; Westin JR; Turturro F
Br J Haematol; 2015 Mar; 168(6):784-95. PubMed ID: 25529575
[TBL] [Abstract][Full Text] [Related]
88. New chromosome abnormalities and lack of BCL-6 gene rearrangements in Argentinean diffuse large B-cell lymphomas.
Cerretini R; Noriega MF; Narbaitz M; Slavutsky I
Eur J Haematol; 2006 Apr; 76(4):284-93. PubMed ID: 16519699
[TBL] [Abstract][Full Text] [Related]
89. Molecular structure of double reciprocal translocations: significance in B-cell lymphomagenesis.
Koduru PR; Offit K
Oncogene; 1991 Jan; 6(1):145-8. PubMed ID: 1992441
[TBL] [Abstract][Full Text] [Related]
90. MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis.
Huh YO; Lin KI; Vega F; Schlette E; Yin CC; Keating MJ; Luthra R; Medeiros LJ; Abruzzo LV
Br J Haematol; 2008 Jul; 142(1):36-44. PubMed ID: 18477041
[TBL] [Abstract][Full Text] [Related]
91. The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma.
Esteve-Arenys A; Valero JG; Chamorro-Jorganes A; Gonzalez D; Rodriguez V; Dlouhy I; Salaverria I; Campo E; Colomer D; Martinez A; Rymkiewicz G; Pérez-Galán P; Lopez-Guillermo A; Roué G
Oncogene; 2018 Apr; 37(14):1830-1844. PubMed ID: 29353886
[TBL] [Abstract][Full Text] [Related]
92. T(14;18)(q32;q21) involving MALT1 and IGH genes in an extranodal diffuse large B-cell lymphoma.
Cook JR; Sherer M; Craig FE; Shekhter-Levin S; Swerdlow SH
Hum Pathol; 2003 Nov; 34(11):1212-5. PubMed ID: 14652825
[TBL] [Abstract][Full Text] [Related]
93. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
[TBL] [Abstract][Full Text] [Related]
94. Advances in pathological understanding of high-grade B cell lymphomas.
Li S; Lin P; Medeiros LJ
Expert Rev Hematol; 2018 Aug; 11(8):637-648. PubMed ID: 29989509
[TBL] [Abstract][Full Text] [Related]
95.
Soliman DS; Al-Sabbagh A; Ibrahim F; Fareed S; Talaat M; Yassin MA
J Hematol; 2017 Sep; 6(2-3):62-67. PubMed ID: 32300395
[TBL] [Abstract][Full Text] [Related]
96. MYC in Germinal Center-derived lymphomas: Mechanisms and therapeutic opportunities.
Bisso A; Sabò A; Amati B
Immunol Rev; 2019 Mar; 288(1):178-197. PubMed ID: 30874346
[TBL] [Abstract][Full Text] [Related]
97. Diagnostic challenges in a case of B cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
So CC; Yung KH; Chu ML; Wan TS
Int J Hematol; 2013 Oct; 98(4):478-82. PubMed ID: 23959583
[TBL] [Abstract][Full Text] [Related]
98. Primary Chest Wall MYC/BCL6 Double-hit Lymphoma with t (3;7) (q27;p12) and t (8;14) (q24;q32) Translocations.
Kamachi K; Kubota Y; Nagaie T; Yamaguchi K; Ogusu S; Kidoguchi K; Kusaba K; Kizuka-Sano H; Nishioka A; Yoshimura M; Yokoo M; Ando T; Kai K; Kojima K; Ohshima K; Sueoka E; Kimura S
Intern Med; 2019 Jul; 58(14):2073-2077. PubMed ID: 30918199
[TBL] [Abstract][Full Text] [Related]
99. MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas.
Ladanyi M; Offit K; Jhanwar SC; Filippa DA; Chaganti RS
Blood; 1991 Mar; 77(5):1057-63. PubMed ID: 1671647
[TBL] [Abstract][Full Text] [Related]
100. Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with
Miyaoka M; Kikuti YY; Carreras J; Ito A; Ikoma H; Tomita S; Kawada H; Roncador G; Bea S; Campo E; Nakamura N
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
